Enclosed are comments regarding the OEHHA draft report entitled " Health Effects Assessment: Potential Neurobehavioral Effects of Synthetic Food Dyes in Children."
CHPA released the following statement in response to ongoing efforts by the U.S. Food and Drug Administration (FDA) to keep hand sanitizers that contain harmful substances off the market.
Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.
The 2019 results from the NIDA and University of Michigan’s annual drug abuse survey, Monitoring the Future, show that the number of teens using OTC cough medicine containing DXM to get high decreased slightly.
CHPA today applauds the U.S. Food and Drug Administration for enforcing existing provisions in the Federal Food, Drug, and Cosmetic Act by sending warning letters to 15 companies illegally marketing cannabidiol products.
Michigan Governor Gretchen Whitmer today signed HB 4412, legislation to combat teen abuse of OTC medicines containing the cough suppressant dextromethorphan (DXM).
Today CHPA submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol in dietary supplements.
Through several CHPA member company donations, 144 U.S. schools of pharmacy received over 100 different OTC medicines, medical devices, and dietary supplements to educate and prepare future pharmacists.
